{"doi":"10.1093/abt/tbab021","title":"Targeting the cancer neoantigens p53 and KRAS with TCR mimic antibodies","abstract":"Recent publications describe TCR mimic antibodies targeting the mutation-associated neoantigens as peptide/HLA class I complexes, which are derived from the intracellular antigens p53 or KRAS and displayed on the cell surface. They have promising effects in the form of diabodies and might provide “off-the-shelf” protein immunotherapy for cancer treatment.","journal":"Antibody Therapeutics","year":2021,"id":204565,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":4,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.95,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":255131,"name":"Mitchell Ho","orcid":"0000-0002-9152-5405","position":1,"is_corresponding":false},{"id":255122,"name":"Zhijian Duan","orcid":"0000-0002-2456-3348","position":0,"is_corresponding":true}],"reference_count":12,"raw_metadata":null,"created_at":"2026-07-18T23:51:26.121843Z","pmid":"34661061","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}